Congestive heart failure: Difference between revisions

	Congestive Heart Failure Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology Systolic Dysfunction Diastolic Dysfunction HFpEF HFrEF
Causes
Differentiating Congestive heart failure from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Clinical Assessment
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
Cardiac MRI
Echocardiography
Exercise Stress Test
Myocardial Viability Studies
Cardiac Catheterization
Other Imaging Studies
Other Diagnostic Studies
Treatment
Invasive Hemodynamic Monitoring
Medical Therapy:
Summary
Acute Pharmacotherapy
Chronic Pharmacotherapy in HFpEF
Chronic Pharmacotherapy in HFrEF Diuretics ACE Inhibitors Angiotensin receptor blockers Aldosterone Antagonists Beta Blockers Ca Channel Blockers Nitrates Hydralazine Positive Inotropics Anticoagulants Angiotensin Receptor-Neprilysin Inhibitor Antiarrhythmic Drugs Nutritional Supplements Hormonal Therapies Drugs to Avoid Drug Interactions Treatment of underlying causes Associated conditions
Exercise Training
Surgical Therapy: Biventricular Pacing or Cardiac Resynchronization Therapy (CRT) Implantation of Intracardiac Defibrillator Ultrafiltration Cardiac Surgery Left Ventricular Assist Devices (LVADs) Cardiac Transplantation
ACC/AHA Guideline Recommendations Initial and Serial Evaluation of the HF Patient Hospitalized Patient Patients With a Prior MI Sudden Cardiac Death Prevention Surgical/Percutaneous/Transcather Interventional Treatments of HF Patients at high risk for developing heart failure (Stage A) Patients with cardiac structural abnormalities or remodeling who have not developed heart failure symptoms (Stage B) Patients with current or prior symptoms of heart failure (Stage C) Patients with refractory end-stage heart failure (Stage D) Coordinating Care for Patients With Chronic HF Quality Metrics/Performance Measures
Implementation of Practice Guidelines
Congestive heart failure end-of-life considerations
Specific Groups: Special Populations Patients who have concomitant disorders Obstructive Sleep Apnea in the Patient with CHF NSTEMI with Heart Failure and Cardiogenic Shock
Congestive heart failure On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Congestive heart failure
CDC on Congestive heart failure
Congestive heart failure in the news
Blogs on Congestive heart failure
Directions to Hospitals Treating Congestive heart failure
Risk calculators and risk factors for Congestive heart failure

	Heart failure;
ICD-10	I50.0
ICD-9	428.0
DiseasesDB	16209
MedlinePlus	000158
MeSH	D006333

VisualWikitext

Revision as of 02:44, 4 April 2012

For patient information click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]; Atif Mohammad, M.D.

Synonyms and Related Key Words: CHF, pump failure, left heart failure, right heart failure, chronic heart failure, acute heart failure, flash pulmonary edema, congestion, systolic dysfunction, LV dysfunction, LV failure, impaired filling, reduced cardiac output, pulmonary edema

Overview

Classification

Pathophysiology

Epidemiology and Demographics

Causes

Risk Factors

Differential Diagnosis

Natural history, complications & prognosis

Diagnosis

Treatment

Medical Therapy:

Acute Pharmacotherapy

Surgical Therapy:

Discharge Care

Guideline Recommendations

Hospitalized Patients

Patients at high risk for developing heart failure (Stage A)

Patients with cardiac structural abnormalities or remodeling who have not developed heart failure symptoms (Stage B)

Patients with current or prior symptoms of heart failure (Stage C)

Patients with refractory end-stage heart failure (Stage D)

Implementation of Practice Guidelines

End-Of-Life Considerations

Specific Groups

Special Populations | Patients who have concomitant disorders | Obstructive Sleep Apnea in the Patient with CHF

Guidelines Resources

The ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult ^[1]

2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation ^[2]

References

↑ Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG et al. (2005) ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 112 (12):e154-235. DOI:10.1161/CIRCULATIONAHA.105.167586 PMID: 16160202
↑ Jessup M, Abraham WT, Casey DE, Feldman AM, Francis GS, Ganiats TG et al. (2009) 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 119 (14):1977-2016. DOI:10.1161/CIRCULATIONAHA.109.192064 PMID: 19324967

Template:WikiDoc Sources

[pmid16160202-1] Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG et al. (2005) ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 112 (12):e154-235. DOI:10.1161/CIRCULATIONAHA.105.167586 PMID: 16160202

[pmid19324967-2] Jessup M, Abraham WT, Casey DE, Feldman AM, Francis GS, Ganiats TG et al. (2009) 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 119 (14):1977-2016. DOI:10.1161/CIRCULATIONAHA.109.192064 PMID: 19324967

[1]

[2]

@@ Line 38: / Line 38: @@
 [[Congestive heart failure clinical assessment|Clinical Assessment]] | [[Congestive heart failure history and symptoms|History & Symptoms]] | [[Congestive heart failure physical examination|Physical Examination]] | [[Congestive heart failure laboratory tests|Lab Tests]] | [[Congestive heart failure electrocardiogram|Electrocardiogram]] | [[Congestive heart failure chest x ray|Chest X Ray]] | [[Congestive heart failure echocardiography|Echocardiography]] | [[Congestive heart failure other diagnostic studies|Other Diagnostic Studies]]
-==[[Congestive heart failure overview of treatment|Treatment]]==
+==Treatment==
 ====Medical Therapy:====
-:'''[[Congestive heart failure overview of treatment#Acute Pharmacotherapy|Acute Pharmacotherapy]]'''
+: '''[[Congestive heart failure acute pharmacotherapy|Acute Pharmacotherapy]]'''
 : '''Chronic Pharmacotherapy:''' [[Congestive heart failure diuretics|Diuretics]] | [[Congestive heart failure renin angiotensin aldosterone axis inhibitors#Angiotensin converting enzyme inhibitor or ACE Inhibitors|ACE Inhibitors]] | [[Congestive heart failure renin angiotensin aldosterone axis inhibitors#Angiotensin receptor blockers (ARB)|Angiotensin receptor blockers]] | [[Congestive heart failure renin angiotensin aldosterone axis inhibitors#Aldosterone Antagonists|Aldosterone Antagonists]] | [[Congestive heart failure nitrates|Nitrates]] | [[Congestive heart failure anticoagulants|Anticoagulants]] | [[Congestive heart failure beta blockers|Beta Blockers]] | [[Congestive heart failure antiarrhythmic Drugs|Antiarrhythmic Drugs]] | [[Congestive heart failure positive inotropics|Positive Inotropics]] | [[Congestive heart failure metformin|Metformin]] | [[Congestive heart failure calcium channel blockers|Ca Channel Blockers]]
 ====Surgical Therapy:====
 :[[Congestive heart failure biventricular pacing or cardiac resynchronization therapy|Biventricular Pacing or Cardiac Resynchronization Therapy (CRT)]] | [[Congestive heart failure implantation of intracardiac defibrillator|Implantation of Intracardiac Defibrillator]] | [[Congestive heart failure ultrafiltration|Ultrafiltration]] | [[Congestive heart failure left ventricular assist devices|Left Ventricular Assist Devices (LVADs)]] | [[Congestive heart failure cardiac transplantation|Cardiac Transplantation]] | [[Congestive heart failure cardiac surgery|Cardiac Surgery]] | [[Congestive heart failure invasive monitoring|Invasive Monitoring]]
+==[[Congestive heart failure discharge care|Discharge Care]]==
 ==Guideline Recommendations==